tiprankstipranks
Trending News
More News >
Orchestra Biomed Holdings, Inc. (OBIO)
:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Income Statement

Compare
88 Followers

Orchestra BioMed Holdings Income Statement

Last quarter (Q3 2025), Orchestra BioMed Holdings's total revenue was $861.00K, a decrease of -12.77% from the same quarter last year. In Q3, Orchestra BioMed Holdings's net income was $-20.83M. See Orchestra BioMed Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.64M$ 2.76M$ 3.53M$ -782.00K$ 5.70M
Gross Profit
$ 2.43M$ 2.57M$ 3.21M$ -981.00K$ 5.56M
Operating Expenses
$ 66.73M$ 54.08M$ 35.87M$ 20.82M$ 24.31M
Depreciation and Amortization
$ 308.00K$ 287.00K$ 222.00K$ 181.00K$ 137.00K
EBITDA
$ -63.99M$ -51.22M$ -32.44M$ -21.62M$ -18.61M
Operating Income
$ -64.30M$ -51.51M$ -32.66M$ -21.80M$ -18.75M
Other Income/Expenses
$ 3.28M$ 2.39M$ -951.00K$ -1.22M$ -2.60M
Pretax Income
$ -61.02M$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Net Income
$ -61.02M$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Per Share Metrics
Basic EPS
$ -1.66$ -1.48$ -1.32$ -0.02$ -0.01
Diluted EPS
$ -1.66$ -1.48$ -1.32$ -0.02$ -0.01
Weighted Average Shares Outstanding
36.82M 33.23M 25.47M 20.45M 20.45M
Weighted Average Shares Outstanding (Diluted)
36.82M 33.23M 25.47M 20.45M 20.45M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History